NCT06281132View on ClinicalTrials.gov

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 22, 2024

Primary Completion Date

May 7, 2024

Study Completion Date

May 14, 2024

Conditions
Hypertension
Interventions
DRUG

CKD-341, D956

A single dose of 1 tablet under fasting condition

Trial Locations (1)

Unknown

Jeonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY